Impact of supplement with Lactobacillus‐ and Bifidobacterium‐containing yogurt on triple therapy for Helicobacter pylori eradication

  title={Impact of supplement with Lactobacillus‐ and Bifidobacterium‐containing yogurt on triple therapy for Helicobacter pylori eradication},
  author={Bor-Shyang Sheu and J J Wu and Csc Lo and H W Wu and J. ‐H. Chen and Y. ‐S. Lin and M. ‐D. Lin},
  journal={Alimentary Pharmacology \& Therapeutics},
Aim : To test whether supplements of Lactobacillus‐ and Bifidobacterium‐containing yogurt (AB‐Yogurt) affect the success of Helicobacter pylori eradication. 
Effects of multistrain probiotic‐containing yogurt on second‐line triple therapy for Helicobacter pylori infection
The adjuvant effects of probiotic‐containing yogurt on second‐line triple therapy for Helicobacter pylori infection have not been evaluated and the aims of this study were to evaluate the effects of these effects on second-line therapy use of yogurt.
Probiotics‐Containing Yogurts Suppress Helicobacter pylori Load and Modify Immune Response and Intestinal Microbiota in the Helicobacter pylori‐Infected Children
This study tested whether the H. pylori‐infected children have an altered gut microflora, and whether probiotics‐containing yogurt can restore such change and improve their H. Pylori-related immune cascades.
Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
Recent evidence found probiotics could inhibit Helicobacter pylori colonization from both in vitro and in vivo studies.
Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis
Fermented milk containing Lj1, coadministered with antibiotics had a favourable effect on H. pylori gastritis and in vitro and in vivo inhibitory effect on Helicobacter pylory.
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy – a placebo‐controlled, double‐blind randomized pilot study
The objective of this study was to establish whether the presence of H. pylori in the blood stream of patients with a history of chronic gastritis and ulcerative colitis increases the likelihood of their developing gastric cancer.
Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori
Aim : To identify optimal antibiotics for second‐line quadruple therapy of Helicobacter pylori after failed 1‐week triple therapy.
Probiotics in Health - A Bug for What is Bugging You
In contrast to probiotics which are a live microbial additions, a prebiotic is a nonviable component of the diet that reaches the colon in an intact form and is selectively fermented by colon
Helicobacter pylori Infection in Clinical Practice: Probiotics and a Combination of Probiotics + Lactoferrin Improve Compliance, But Not Eradication, in Sequential Therapy
Background:  Sequential therapy (ST) seems to offer higher success rates than triple therapy (TT) in the eradication of Helicobacter pylori (H. pylori) infection. However, from the standpoint of
Comparison of combination of probiotic and standard therapy compared to standard therapy on eradication of Helicobacter pylori infection in children
Probiotic is reported to give beneficial effect in the management of H. pylori infection in children.
[Linex forte in the prevention and treatment of gastrointestinal diseases].
Dosing recommendations for the drug linex forte to treat gastrointestinal tract diseases in adults and children are stated.


A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
Human Lactobacillus acidophilus shows an in vitro inhibitory effect on the attachment of H. pylori to gastric epithelial cell lines, and culture supernatant of this bacillus seems to decrease the in vitro viability of the organism.
The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer
: To study the efficacy of omeprazole triple therapy in the eradication of Helicobacter pylori in patients with active gastric ulcer, and to assess healing and relapse of gastric ulcer.
Efficacy of a multistep strategy for Helicobacter pylori eradication
Helicobacter pylori eradication therapies do not achieve 100% success rates. Antibiotic resistant strains are among the major causes of failure. Current recommendations concerning the management of
Five‐day regimens containing ranitidine bismuth citrate plus high‐dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection
Ranitidine bismuth citrate (RBC)‐based triple therapies for a period of 7 days have proved to be an effective treatment for Helicobacter pylori.
The DU‐MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy
: To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6‐month treatment‐free period in patients with
Potential of using lactic acid bacteria for therapy and immunomodulation in man.
It is concluded that pursuit of research on beneficial effects of lactic acid bacteria could be promising for ecological therapy of mucosal diseases, and for development of original and flexible vectors for targeting in the gastrointestinal tract.
Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans
La1 culture supernatant shown to be effective in vitro has a partial, acid-independent long-term suppressive effect on H. pylori in humans.
Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
The yeast Saccharomyces boulardii has been shown to be of benefit in the prevention of antibiotic‐associated diarrhoea but not in preventing infection with Clostridium difficile.
Eradication of Helicobacter pylori: an objective assessment of current therapies.
The analysis showed that proton pump inhibitor triple therapy was the preferred treatment for the eradication of H. pylori, and the 1-week, low-dose regimen with omeprazole plus clarithromycin plus tinidazole produced the highest eradication rates with the lowest frequency of side-effects and at only modest cost.
Eradication of Helicobacter pylori: why does it fail?
There is a need for careful medical education and information both as far as concerns doctors and patients, for well-designed prescription, based on local experience and the precise previous history of every patient, as well as for continuous monitoring of the bacterial resistance to antibiotics.